nach oben

Clinical and Translational Oncology

Erschienen in:

01.04.2013 | Educational Series – Red Series

Therapeutic management of epithelial ovarian cancer during pregnancy

verfasst von: L. Minig, L. Otaño, I. Diaz-Padilla, R. Alvarez Gallego, M. G. Patrono, J. Valero de Bernabé

Erschienen in: Clinical and Translational Oncology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Epithelial ovarian cancer (EOC) during pregnancy is a rare condition. The diagnosis and treatment strategies are therefore not well defined. The evidence is scarce and limited to small case reports or case series. In this review we describe the safety, utility and limitations of each diagnostic tool and surgical procedure in pregnant women with ovarian cancer. We also discuss the role of chemotherapy for ovarian cancer during pregnancy. Finally, we delineate different strategies of treatment according to the stage of the disease at diagnosis and gestational age. Due to the complexity of the management of EOC during pregnancy, patients should be referred to specialized centers. Gestational age at diagnosis, the initial surgical procedure, disease stage and patient’s preferences are the key factors in the decision-making process to establish the best treatment strategy for each individual case.

Morice P, Uzan C, Gouy S, Verschraegen C, Haie-Meder C (2012) Gynaecological cancer in pregnancy. Lancet 379:558–569PubMedCrossRef

Malfetano JH, Goldkrand JW (1990) Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma. Obstet Gynecol 75:545–547PubMed

Creasman WT, Rutledge F, Smith JP (1971) Carcinoma of the ovary associated with pregnancy. Obstet Gynecol 38:111–116PubMed

Copeland LJ, London MB (1996) Malignant disease in pregnancy. In: Gabbe SG, Niebyl JR, Simpson JL (eds) Obstetrics, normal, and problem pregnancies, 3rd edn. Churchill Livingstone, New York, pp 1155–1181

Palmer J, Vatish M, Tidy J (2009) Epithelial ovarian cancer in pregnancy: a review of the literature. BJOG 116:480–491PubMedCrossRef

Kobayashi F, Sagawa N, Nakamura K, Nonogaki M, Ban C, Fujii S, Mori T (1989) Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women. Am J Obstet Gynecol 160:563–566PubMed

Halila H, Stenman U, Seppalla M (1986) Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer 57:1327–1329PubMedCrossRef

American College of Obstetricians and Gynecologists. ACOG committee Opinion No 299 (2004) Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 104:647–651CrossRef

Amant F, Van Calsteren K, Halaska MJ, Beijnen J, Lagae L, Hanssens M et al (2009) Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int J Gynecol Cancer 19(Suppl 1):S1–S12PubMedCrossRef

10.

Brenner DJ, Hall EJ (2007) Computed tomography an increasing source of radiation exposure. N Engl J Med 357:2277–2284PubMedCrossRef

11.

Zanotti-Fregonara P, Jan S, Taieb D et al (2010) Absorbed 18F-FDG dose to the fetus during early pregnancy. J Nucl Med 51:803–805PubMedCrossRef

12.

Zanotti-Fregonara P, Champion C, Trébossen R, Maroy R, Devaux JY, Hindié E (2008) Stimulation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy. J Nucl Med 49:679–682PubMedCrossRef

13.

Reedy MB, Källén B, Kuehl TJ (1997) Laparoscopy during pregnancy: a study of five fetal outcome parameters with use of the Swedish Health Registry. Am J Obstet Gynecol 177:673–679PubMedCrossRef

14.

Akira S, Yamanaka A, Ishihara T, Takeshita T, Araki T (1999) Gasless laparoscopic ovarian cystectomy during pregnancy: comparison with laparotomy. Am J Obstet Gynecol 180:554–557PubMedCrossRef

15.

Friedman JD, Ramsey PS, Ramin KD et al (2002) Pneumoamnion and pregnancy loss after second-trimester laparoscopic surgery. Obstet Gynecol 299:512–513CrossRef

16.

Sayedur Rahman M, Al-Sibai MH, Rahman J, Al-Suleiman SA, El-Yahia AR, Al-Mulhim AA et al (2002) Ovarian carcinoma associated with pregnancy. A review of 9 cases. Acta Obstet Gynecol Scand 81:260–264PubMedCrossRef

17.

Ferrandina G, Distefano M, Testa A, De Vincenzo R, Scambia G (2005) Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review. Gynecol Oncol 97:693–696PubMedCrossRef

18.

Stuart GC, Kitchener H, Bacon M, duBois A, Friedlander M, Ledermann J, Marth C, Thigpen T, Trimble E, Participants of 4th Ovarian Cancer Consensus Conference (OCCC), Gynecologic Cancer Intergroup (2011) 2010 gynecologic cancer intergroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the fourth ovarian cancer consensus conference. Int J Gynecol Cancer 21(4):750–755

19.

Mercer BM (2003) Preterm premature rupture of the membranes. Obstet Gynecol 101:178–193PubMedCrossRef

20.

NIH (2000) Antenatal corticosteroids revisited: repeat courses. NIH consensus statement 2000 August 17–18. Am J Obstet Gynecol 17(2):1–18

21.

Teratology Society Public Affairs Committee (1994) FDA classification of drugs for teratogenic risk. Teratology 49:446–447CrossRef

22.

Brewer M, Kueck A, Runowicz C (2011) Chemotherapy in pregnancy. Clin Obstet Gynecol 54(4):602–618PubMedCrossRef

23.

Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5:283–291PubMedCrossRef

24.

Ebert U, Loffler H, Kirch W (1997) Cytotoxic therapy and pregnancy. Pharmacol Ther 74:207–220PubMed

25.

Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W et al (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28:683–689PubMedCrossRef

26.

Mir O, Berveiller P, Ropert S, Goffinet F, Goldwasser F (2008) Use of platinum derivatives during pregnancy. Cancer 113:3069–3074PubMedCrossRef

27.

Li RH, Tam WH, Ng PC, Mok TS, Tam B, Lau TK (2007) Microphthalmos associated with Dartmouth combination chemotherapy in pregnancy: a case report. J Reprod Med 52:575–576PubMed

28.

Henderson C, Elia G, Garfinkel D, Poirier MC, Shamkhani H, Runowicz CD (1993) Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary. Gynecol Oncol 49:92–94PubMedCrossRef

29.

Koc O, McFee M, Reed E, Gerson SL (1994) Detection of platinum-DNA adducts in cord blood lymphocytes following in utero platinum exposure. Eur J Cancer 30:716–717CrossRef

30.

Picone O, Lhommé C, Tournaire M, Pautier P, Camatte S, Vacher-Lavenue MC et al (2004) Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review. Gynecol Oncol 94:600–604PubMedCrossRef

31.

Tabata T, Nishiura K, Tanida K, Kondo E, Okugawa T, Sagawa N (2008) Carboplatin chemotherapy in a pregnant patient with undifferentiated ovarian carcinoma: case report and review of the literature. Int J Gynecol Cancer 18:181–184PubMedCrossRef

32.

Mir O, Berveiller P, Goffinet F, Treluyer JM, Serreau R, Goldwasser F et al (2010) Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol 21:425–426PubMedCrossRef

33.

Cardonick E, Usmani A, Ghaffar S (2010) Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol 33:221–228PubMed

34.

FIGO, Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U (2006) Carcinoma of the ovary. FIGO 6th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95:S161–S192PubMedCrossRef

35.

Tropé C, Kaern J (2007) Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature. J Clin Oncol 25:2909–2920PubMedCrossRef

36.

American College of Obstetricians and Gynecologists (2007) ACOG practice bulletin: management of adnexal masses. Obstet Gynecol 110:201–214CrossRef

37.

Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S et al (2010) Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol 28:1727–1732PubMedCrossRef

38.

Colombo N, Guthrie D, Chiari S, Parmar M, Qian W, Swart AM, International collaborative ovarian neoplasm (ICON) collaborators et al (2003) International collaborative ovarian neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 95:125–132PubMedCrossRef

39.

Trimbos JB, Parmar M, Vergote I, Guthrie D, Bolis G, Colombo N, International Collaborative Ovarian Neoplasm 1, European Organisation for Research and Treatment of Cancer Collaborators–Adjuvant Chemotherapy in Ovarian Neoplasm et al (2003) Impact of adjuvant chemotherapy and surgical staging in early stage ovarian carcinoma: European organisation for research and treatment of cancer–adjuvant chemotherapy in ovarian neoplasm trial. J Natl Cancer Inst 95:113–125PubMedCrossRef

40.

Marret H, Lhommé C, Lecuru F, Canis M, Lévèque J, Golfier F et al (2010) Guidelines for the management of ovarian cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 149:18–21PubMedCrossRef

41.

Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248–1259PubMedCrossRef

42.

Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N et al, European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group, NCIC Clinical Trials Group (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363:943–953PubMedCrossRef

Titel: Therapeutic management of epithelial ovarian cancer during pregnancy
verfasst von: L. Minig
L. Otaño
I. Diaz-Padilla
R. Alvarez Gallego
M. G. Patrono
J. Valero de Bernabé
Publikationsdatum: 01.04.2013
Verlag: Springer Milan
Erschienen in: Clinical and Translational Oncology / Ausgabe 4/2013
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-012-0963-3

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Therapeutic management of epithelial ovarian cancer during pregnancy

Abstract

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2013

Hypofractionated helical tomotherapy using 2.5–2.6 Gy daily fractions for localized prostate cancer

Impact of radiotherapy delay on survival in glioblastoma

Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients

Dynamic regulation of cancer stem cells and clinical challenges

Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer

Zoledronic acid and radiation: toxicity, synergy or radiosensitization?

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie